Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-03

Clinical Trial Update: Safe Use of Heparin Sodium in Patients With Chronic Renal Failure. [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on the safe use of heparin sodium in patients with chronic renal failure; study status is suspended for Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HEPARIN SODIUM (HEPARIN SODIUM)

Snippet

Sponsor: Azidus Brasil | Conditions: Chronic Renal Failure | Phase 2, Phase 3 | Status: SUSPENDED